Thus, defects in ankyrin-B-based pathways primarily impact cardiac pacemaking, and atrial and ventricular arrhythmia (mostly through increased likelihood of arrhythmia triggers, as opposed to conduction defects). The gene discussed is ANK2; the disease is Ventricular arrhythmia.